• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Boston Scientific

Boston Scientific

Boston Scientific Inc BSX 2 Star

Last Price$18.27Day Change (%)1.56%
Open Price$17.97Day Change ($)0.28
Day Range17.90–18.4552-Week Range11.10–18.50

As of Thu 5/28/2015 6:33:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. UPDATE: Transports' death cross raises -2-

    UPDATE: Transports' death cross raises -2-

  2. Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2015

    Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2015

  3. Boston Scientific Prices $1.85 Billion Of Senior Notes

    Boston Scientific Prices $1.85 Billion Of Senior Notes

  4. Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

    Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

  5. An S&P 500 breakout attempt remains in play -2-

    An S&P 500 breakout attempt remains in play -2-

  6. Global Peripheral Vascular Devices Market to Reach US$7.8 Billion by 2018: Transparency Market Research

    Global Peripheral Vascular Devices Market to Reach US$7.8 Billion by 2018: Transparency Market Research

  7. Research and Markets: Global Medical Devices Market 2012-2020: Market Size, Share, Trends, Analysis and Forecasts for the $289 Billion Market

    Research and Markets: Global Medical Devices Market 2012-2020: Market Size, Share, Trends, Analysis and Forecasts for the $289 Billion Market

  8. New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

    New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

  9. Nevro Announces Filing of Petitions for Inter Partes Review of U.S. Patent No. 8,359,102

    Nevro Announces Filing of Petitions for Inter Partes Review of U.S. Patent No. 8,359,102

  10. Bad Investor Behavior: Overemphasizing Experience

    Abbott Labs ABT had a strong showing at the American College of Cardiology's annual meeting this weekend, but the news was less positive for Boston Scientific BSX and partner Angiotech ANPI. Abbott revealed data from a head-to-head trial that demonstrated its Xience V drug-eluting stent performed ...

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.